Drug class
Rabies Immune Globulin
Rabies immune globulin is a class of passive immunizing biological agents containing concentrated anti-rabies virus antibodies derived from hyperimmunized human or equine plasma. Read more about Rabies Immune Globulin
5 drugs in this class 3 manufacturers
Drugs in Rabies Immune Globulin
KEDRAB (rabies immune globulin/PF)
IMOGAM RABIES-HT (PF) (rabies immune globulin/PF)
HYPERRAB (PF) (rabies immune globulin/PF)
KEDRAB (PF) (rabies immune globulin/PF)
Rabies immune globulin is a class of passive immunizing biological agents containing concentrated anti-rabies virus antibodies derived from hyperimmunized human or equine plasma.
It works by immediately neutralizing the rabies virus locally and systemically, providing transient passive immunity during the critical window before the patient mounts an active antibody response to vaccination.
Clinically, it is indicated exclusively as part of post-exposure prophylaxis—administered alongside a rabies vaccine regimen following animal bites or contact with confirmed or suspected rabid animals—to prevent the onset of fatal rabies infection in previously unimmunized individuals.
-
fda.gov
Rabies immune globulin is a class of passive immunizing biological agents containing concentrated anti-rabies virus antibodies derived from hyperimmunized human or equine plasma It works by immediately neutralizing the rabies virus locally and systemically, providing transient passive immunity during the critical window before the patient mounts an active antibody response to vaccination Clinically, it is indicated exclusively as part of post-exposure prophylaxis—administered alongside a rabies ...
-
fda.gov
Rabies immune globulin is a class of passive immunizing biological agents containing concentrated anti-rabies virus antibodies derived from hyperimmunized human or equine plasma
-
fda.gov
Rabies immune globulin is a class of passive immunizing biological agents containing concentrated anti-rabies virus antibodies derived from hyperimmunized human or equine plasma
-
fda.gov
It works by immediately neutralizing the rabies virus locally and systemically, providing transient passive immunity during the critical window before the patient mounts an active antibody response to vaccination
-
restoredcdc.org
Clinically, it is indicated exclusively as part of post-exposure prophylaxis—administered alongside a rabies vaccine regimen following animal bites or contact with confirmed or suspected rabid animals—to prevent the onset of fatal rabies infection in previously unimmunized individuals
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.